Shorter infusion time of ocrelizumab: results from the ensemble plus study in patients with relapsing-remitting multiple sclerosis

被引：0

作者：

Brochet, B. ^{[1
]}

Berger, T. ^{[2
]}

Bermel, R. ^{[3
]}

Freedman, M. ^{[4
,5
]}

Hartung, H. P. ^{[6
,7
]}

Holmoy, T. ^{[8
]}

Killestein, J. ^{[9
]}

Ross, A. Perrin ^{[10
]}

Buffels, R. ^{[11
]}

Garas, M. ^{[11
]}

Kadner, K. ^{[11
]}

Schneble, H. -M. ^{[11
]}

Wang, Q. ^{[11
]}

Nos, C. ^{[12
]}

机构：

[1] Univ Bordeaux, Bordeaux, France

[2] Med Univ Vienna, Dept Neurol, Vienna, Austria

[3] Cleveland Clin, Mellen Ctr MS, Cleveland, OH 44106 USA

[4] Univ Ottawa, Ottawa, ON, Canada

[5] Ottawa Hosp Res Inst, Ottawa, ON, Canada

[6] Heinrich Heine Univ, Dept Neurol, Ctr Neurol & Neuropsychiat, UKD, Dusseldorf, Germany

[7] Heinrich Heine Univ, LVR Klinikum, Dusseldorf, Germany

[8] Akershus Univ Hosp, Dept Neurol, Lorenskog, Norway

[9] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands

[10] Loyola Univ, Chicago, IL 60611 USA

[11] F Hoffmann La Roche Ltd, Basel, Switzerland

[12] Vall dHebron Hosp Univ, Ctr Esclerosi Multiple Catalunya Cemcat, Barcelona, Spain

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P0392

引用

页码：307 / 308

页数：2